AstraZeneca's Oxford coronavirus vaccine is 70% effective on average, 데이터 쇼

Drugmaker AstraZeneca announced on Monday that its experimental 코로나 바이러스 vaccine has shown an average efficacy of 70% in its large scale trialsthe latest of several vaccine trials worldwide to post their results this month.

The vaccine, developed with the University of Oxford, 보여 주었다 90% efficacy in one dosing regimenwhen the vaccine was given as a half dose, followed by a full dose at least a month later — 과 62% efficacy in a second regimenwhen two full doses were given at least a month apart.
That averages to a 70% efficacy, AstraZeneca said.
The company said in a news release that its vaccine washighly effective in preventing COVID-19, the primary endpoint, and no hospitalisations or severe cases of the disease were reported in participants receiving the vaccine.
    The interim analysis included a total of 131 코로나 19 사례, 릴리스에 따라.
      Monday’s news comes after Moderna announced earlier this month that its vaccine was 94.5% effective against coronavirus, 과 화이자 announced its vaccine was 95% 유효한.
      이것은 발전하는 이야기입니다 … more to follow

      답장을 남겨주세요

      귀하의 이메일 주소는 공개되지 않습니다. 필요 입력 사항은 표시되어 있습니다 *